Flexion Therapeutics FLXN 深 沪
等待开盘 07-18 09:30:00 美东时间
25.005
+0.020
+0.08%
华盛通- 最 高25.005
- 今 开--
- 成交量 0股
- 最 低 25.005
- 昨 收 24.985
- 总市值 12.58亿
- 52周最高 25.0799
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.30
- 委 比 0.00%
- 总股本 5032.14万
- 历史最高 32.25
- 量 比 0
- 振 幅 0.00%
- 历史最低 4.30
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Horizon Expands ETF Lineup With 2 Funds For Smarter Bond Income And Volatility Defense
Horizon introduces 2 new ETFs for financial advisors - BNDY and FLXN - to help manage risk and enhance returns in complex markets.
07-08 04:05
Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA)
Lexicon Pharmaceuticals announced that a post-hoc analysis of data from clinical trials showed that adding sotagliflozin to optimized insulin therapy significantly reduced hypoglycemic events, particularly in individuals with type 1 diabetes (T1D) experiencing blood glucose levels ≤55 mg/dL. The study, presented at the American Diabetes Association's 85th Scientific Sessions, evaluated the impact of kidney function on hypoglycemia risk using esti...
06-23 12:00
Pacira生物科学公司完成对屈曲治疗公司的收购并加强在非阿片类疼痛管理方面的领先地位
-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Comb...
2021-11-19 21:46
Alentis Therapeutics宣布任命Luca Santarelli为董事会成员，Rafaèle Tordjman为董事长
瑞士巴塞尔--(BUSINESS WIRE)--(美国商业资讯)--开发纤维化疾病突破性治疗药物的瑞士生物技术公司Alentis Therapeutics今天宣...
2021-11-15 17:20
股东通知：Brodsky&Smith公司宣布对Flexion治疗公司(纳斯达克-FLXN)进行调查
BALA CYNWYD, PA / ACCESSWIRE / October 13, 2021 / Law office of Brodsky & S...
2021-10-13 19:18
药闻头条丨Moderna急了！敦促FDA授权加强针，赛生新抗生素拟上市
欧康维视自研干眼症药首度获批临床；歌礼慢性乙肝药将公布二期临床数据；阿斯利康在华设立全球研发中心>>
2021-10-13 13:37
屈曲疗法的分析师评级如何确定分析师评级？
Over the past 3 months, 4 analysts have published their opinion on Flexion Ther...
2021-10-12 12:27
BMO Capital Downgrades Flexion Therapeutics to Market Perform, Lowers Price Target to $12
BMO Capital analyst Gary Nachman downgrades Flexion Therapeutics (NASDAQ:FLXN) ...
2021-10-12 07:26
生物制药公司Flexion(FLXN.O)涨超70%，药品制造商Pacir...
生物制药公司Flexion(FLXN.O)涨超70%，药品制造商Pacira Biosciences(PCRX.O)据悉与Flexion接近达成6.3亿美元的收...
2021-10-11 21:31
